| Serial Number | 79435559 |
| Word Mark | OBSEGONE |
| Filing Date | Wednesday, April 23, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, June 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Drugs for medical purposes, namely, medical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparation for treating alcoholic fatty liver; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of alzheimer's disease; diet tea for medical purposes; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); slimming pills; appetite suppressant pills; pharmaceutical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); cardiovascular pharmaceuticals for medical use; medicines for human purposes, namely, medicinal preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); appetite suppressants for medical purposes; biological preparations for medical purposes for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparations for slimming purposes; medical preparation for treating diabetes; slimming tea for medical purposes; antidiabetic pharmaceuticals; antidiabetic preparation; cardiovascular pharmaceutical preparations; lipotropic factor preparation; dietetic supplements adapted for medical use; diabetic bread adapted for medical use; dietetic beverages featuring fruit juices with pulp adapted for medical purposes, for use by diabetic patients. |
| Description of Mark | The mark consists of the wording "OBSEGONE" in stylized font. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SHANGHAI INNOGEN |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Event Date | Event Description |
| Thursday, October 30, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, November 1, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 1, 2025 | APPLICATION FILING RECEIPT MAILED |
| Sunday, November 2, 2025 | ASSIGNED TO EXAMINER |
| Friday, November 7, 2025 | NON-FINAL ACTION WRITTEN |
| Saturday, November 8, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, November 27, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, December 17, 2025 | REFUSAL PROCESSED BY MPU |
| Wednesday, December 17, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, January 1, 2026 | REFUSAL PROCESSED BY IB |
| Wednesday, June 3, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 3, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 3, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |